Clinical Trials
6 trialsNCT06770582 2026-06-03
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT06388720 2026-05-29
IMGeS
National Cancer Center, Korea
Phase 2 Recruiting
NCT04779554 2026-04-01
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
Phase 2 Recruiting
NCT05672108 2026-03-05
Phase II Trial of Lung Chemoemobolization
City of Hope Medical Center
Phase 2 Recruiting
NCT04107077 2025-10-07
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
University of Chicago
Phase 2 Recruiting
NCT05024734 2025-03-11
GAIN INST
Hospital Centre Biel/Bienne
Phase 2 Recruiting